Brazil Launches First Domestically Developed Dengue Vaccine with 2025 Rollout

0
cd187ec0-830b-4b6f-a001-1b344da84637

Brazil has announced the launch of its first domestically produced dengue vaccine, with nationwide distribution set for 2025. This vaccine, showing efficacy against all dengue serotypes, will have an initial rollout of 60 million doses through public health channels. A 2024 immunization campaign has already begun, targeting millions of children to bolster national health efforts.

Brazil has announced its first locally produced dengue vaccine, spearheaded by President Luiz Inacio Lula da Silva. This initiative includes an investment of approximately $221 million to advance immunization efforts against dengue, influenza H5N8, and respiratory syncytial virus (RSV). The vaccine has shown efficacy against all four serotypes of the dengue virus and will play a vital role in combatting outbreaks across the nation.

In 2025, the Brazilian public healthcare system will distribute at least 60 million doses of the vaccine nationwide. In preparation, a nationwide immunization campaign was launched in 2024 to target 3.3 million children aged 10 to 14. This locally developed vaccine is expected to enhance access to dengue protection and bolster ongoing national immunization efforts.

The introduction of Brazil’s first domestically produced dengue vaccine marks a significant advancement in public health. With a nationwide rollout planned for 2025 and substantial investments in vaccine development, Brazil aims to mitigate the effects of dengue through widespread immunization. This initiative demonstrates Brazil’s commitment to improving health outcomes and protecting its population from infectious diseases.

Original Source: tvbrics.com

Leave a Reply

Your email address will not be published. Required fields are marked *